61
Resistant Hypertension Optimal Treatment
Condition(s):HypertensionLast Updated:June 7, 2013Unknown status
THALITONE: 84 Clinical Trials, Page 7 of 9
Hide Studies Not Open or Pending
62
Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation
Condition(s):HypertensionLast Updated:February 7, 2017Terminated
63
Systolic Hypertension in the Elderly Program (SHEP)
Condition(s):Cardiovascular Diseases; Cerebrovascular Disorders; Heart Diseases; HypertensionLast Updated:April 15, 2016Completed
64
Efficacy & Safety Study of YH22162 vs Telmisartan/Amlodipine in Patients With Hypertension Inappropriately Controlled on Telmisartan/Amlodipine Treatment
Condition(s):HypertensionLast Updated:March 11, 2019Completed
65
Trial of Antihypertensive Intervention Management
Condition(s):Cardiovascular Diseases; Heart Diseases; Hypertension; Vascular DiseasesLast Updated:November 26, 2013Completed
66
A Pilot Study of the Impact of the Patient Activated Learning System (PALS) on Knowledge Acquisition, Recall, and Decision Making
Condition(s):Patient EducationLast Updated:April 23, 2019Completed
67
Sequential Nephron Blockade vs. Dual Blockade Renin-angiotensin System + Bisoprolol in Resistant Arterial Hypertension
Condition(s):Hypertension Resistant to Conventional TherapyLast Updated:April 5, 2019Completed
68
Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study)
Condition(s):Cardiovascular Diseases; Heart Diseases; Hypertension; Vascular DiseasesLast Updated:November 26, 2013Completed
69
Evaluation of the Tubular Effects of Dapagliflozin Using 1HNMR Spectroscopy
Condition(s):DiabetesLast Updated:April 19, 2019Completed
70
Hypertension Management in Family Practice
Condition(s):HypertensionLast Updated:July 6, 2018Unknown status